- Home
- SWIN vs RADX Comparison
SWIN vs RADX Comparison
Compare SWIN & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- RADX
- Stock Information
- Founded
- SWIN 2017
- RADX 2021
- Country
- SWIN Hong Kong
- RADX Australia
- Employees
- SWIN N/A
- RADX N/A
- Industry
- SWIN
- RADX
- Sector
- SWIN
- RADX
- Exchange
- SWIN Nasdaq
- RADX NYSE
- Market Cap
- SWIN 214.1M
- RADX 32.5M
- IPO Year
- SWIN 2023
- RADX N/A
- Fundamental
- Price
- SWIN $3.80
- RADX $4.81
- Analyst Decision
- SWIN
- RADX Strong Buy
- Analyst Count
- SWIN 0
- RADX 3
- Target Price
- SWIN N/A
- RADX $15.00
- AVG Volume (30 Days)
- SWIN 216.6K
- RADX 18.6K
- Earning Date
- SWIN 08-21-2025
- RADX 02-26-2025
- Dividend Yield
- SWIN N/A
- RADX N/A
- EPS Growth
- SWIN N/A
- RADX N/A
- EPS
- SWIN N/A
- RADX N/A
- Revenue
- SWIN $3,316,000.00
- RADX $204,609.00
- Revenue This Year
- SWIN $29.79
- RADX N/A
- Revenue Next Year
- SWIN $54.60
- RADX N/A
- P/E Ratio
- SWIN N/A
- RADX N/A
- Revenue Growth
- SWIN N/A
- RADX N/A
- 52 Week Low
- SWIN $1.16
- RADX $3.50
- 52 Week High
- SWIN $4.40
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- SWIN 59.60
- RADX N/A
- Support Level
- SWIN $3.29
- RADX N/A
- Resistance Level
- SWIN $3.99
- RADX N/A
- Average True Range (ATR)
- SWIN 0.39
- RADX 0.00
- MACD
- SWIN -0.04
- RADX 0.00
- Stochastic Oscillator
- SWIN 80.93
- RADX 0.00
About SWIN Solowin Holdings
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.